The article reports on the Cambridge Healthtech Institute's (CHI) Exploring Next Generation Sequencing conference. In his keynote address, scientist-entrepreneur Kevin Ulmer discussed the pros and cons of several next-generation sequencing technologies. The final draft of James Watson's genome was discussed by David Wheeler. Several startups companies were featured, including Reveo and NABsys. INSET: Genome Corp. Born Again.